UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000040956 |
|---|---|
| Receipt number | R000046770 |
| Scientific Title | Effect of a monoclonal antibody to sclerostin (romosozumab) on dialysis patients with osteoporosis |
| Date of disclosure of the study information | 2020/09/01 |
| Last modified on | 2024/02/15 12:48:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/06/30 15:53:56 | ||
| 2 | Update | 2020/11/30 11:49:52 | Anticipated trial start date |
|
| 3 | Update | 2021/06/02 05:47:08 | Anticipated trial start date Last follow-up date |
|
| 4 | Update | 2021/08/28 10:32:50 | Last follow-up date |
|
| 5 | Update | 2022/03/02 13:40:14 | Last follow-up date |
|
| 6 | Update | 2022/06/02 16:24:26 | Last follow-up date |
|
| 7 | Update | 2022/12/28 05:58:03 | Last follow-up date |
|
| 8 | Update | 2023/05/29 11:51:04 | Last follow-up date |
|
| 9 | Update | 2024/02/08 16:55:31 | Primary outcomes Primary outcomes |
|
| 10 | Update | 2024/02/15 10:56:43 | Key inclusion criteria Key inclusion criteria Target sample size |
|
| 11 | Update | 2024/02/15 12:31:27 | Number of participants that the trial has enrolled Results Results Results date posted |
|
| 12 | Update | 2024/02/15 12:48:53 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Other related information Other related information |
